To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Other Federal Drug Control Programs for fiscal year 2024.
Impact
The potential implications of HB 2073 are multifaceted. By limiting funding to drug control programs, the bill raises questions about the federal government's ability to effectively combat drug-related issues, particularly as the nation continues to grapple with the opioid crisis and other substance abuses. Advocates for the bill argue that it will encourage a more efficient allocation of resources and force accountability among agencies responsible for drug policy. Critics, however, express concern that reducing funding could hinder ongoing initiatives and support systems, potentially exacerbating the challenges posed by drug abuse in many communities.
Summary
House Bill 2073 is designed to impose limitations on the availability of funds allocated to the Executive Office of the President, specifically targeting the Office of National Drug Control Policy and other federal drug control programs for the fiscal year 2024. The bill stipulates that the total appropriated amounts cannot exceed $118,327,000. This limitation represents a significant cut compared to previous years, aiming to direct federal spending towards other priorities while addressing concerns regarding efficacy and fiscal responsibility in drug control efforts.
Contention
The discussions surrounding HB 2073 are likely to spark debate regarding the balance between fiscal discipline and public health needs. Proponents argue that the current spending levels are unsustainable and that the bill promotes responsible budgeting without undermining the fight against drug abuse. In contrast, opponents argue that the funding cap could lead to dire consequences, with fewer resources available for treatment, prevention, and education programs that are crucial in addressing drug-related issues. This contention reflects broader ideological divides regarding the role of government in managing public health crises and managing fiscal priorities.
This bill provides states with the authority to name post offices located in the state. The bill makes exceptions with respect to federally named post offices.
Close the Medigap Act of 2023 This bill (1) expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies), (2) eliminates certain limitations on Medigap policies for newly eligible Medicare beneficiaries, and (3) modifies other provisions related to Medigap policies. (Guaranteed issue rights require that a policy be offered to any eligible applicant without regard to health status.)
World Deserves To Know Act This bill requires sanctions on certain members of the Chinese Communist Party (CCP) and officials of Chinese health agencies. It also addresses related issues. The President must impose visa- and property-blocking sanctions on any foreign person who is a CCP official and who is knowingly responsible for or complicit in (1) the disappearances of whistleblowers and citizen journalists in China relating to COVID-19, or (2) limiting free speech and academic freedom in China relating to COVID-19. The President must also impose such sanctions on specified individuals who have leadership positions in China's Center for Disease Control and Prevention and China's National Health Commission (NHC). The authority to impose such sanctions shall end when the President certifies to Congress that an independent and unimpeded investigation into the potential origin of COVID-19 from the Wuhan Institute of Virology has taken place. The bill also bars federal funds and certain federal student assistance from going to institutions of higher education that enter into a contract with any element or China-based affiliate of the NHC. Federal funding to the National Academy of Sciences may not be used to enter into a contract with any element or China-based affiliate of the NHC. The Government Accountability Office must report to Congress a review of all funds that the National Institutes of Health have made available to the NHC since FY2010. This report must also be publicly available.
Faithful Execution of the Law Act of 2023 This bill expands the circumstances under which the Department of Justice (DOJ) is required to report to Congress on a policy to refrain from enforcing federal law. Currently, DOJ is required to report to Congress when the Attorney General or other DOJ officer establishes or implements a non-enforcement policy on the grounds that the relevant provision of law is unconstitutional. This bill requires DOJ to report to Congress when any federal officer establishes or implements a non-enforcement policy on any grounds. Further, the bill requires the report to state the grounds for the non-enforcement policy.
Drug Testing for Welfare Recipients Act This bill requires the Temporary Assistance for Needy Families program, the Supplemental Nutrition Assistance Program, and specified public housing programs to subject individuals to substance-abuse screening and to deny benefits for individuals who test positive for a controlled substance.